Search

Search results

Current filters: Treatment, Research summary, Hepatitis C drugs

40 search results

Large review from three French studies finds no link between use of DAAs and recurrence of liver cancer

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Bologna researchers find no link between DAAs and liver cancer

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Vienna doctors urge caution when assessing possible associations between liver cancer recurrence and use of DAAs

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Barcelona: Reports of unexpected cases of liver cancer in people undergoing treatment with DAAs

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Looking back at liver cancer rates among people who received interferon therapy

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Caution needed about claims of increased risk of liver cancer recurrence with use of DAAs

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

DAAs found highly tolerable (and effective) in people with mental health conditions

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

The looming arrival of Epclusa – sofosbuvir + velpatasvir

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

ABT-493 + ABT-530 in genotype 1 with previous DAA therapy failure

From TreatmentUpdate 215
2016, CATIE
Research summary - Webpage

ABT-493 + ABT-530 in genotypes 4, 5 and 6

From TreatmentUpdate 215
2016, CATIE
Research summary - Webpage